A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...
When Pfizer’s US Enbrel sales force gives way to Amgen’s in July, reps risk layoff if they don’t get picked up by Amgen or re-assigned to Pfizer’s new JAK inhibitor. The news that Pfizer was turning ...
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
Drug pricing may be a secretive affair in the U.S., but every quarter, earnings reports offer a peek behind the curtain. This time around, the numbers show pricing power dwindling away in some ...
THOUSAND OAKS, Calif., and RADNOR, Penn., – Results from a study of ENBREL® (etanercept), the only fully human TNF receptor, were presented demonstrating significant inhibition in the progression of ...
The patient waiting list already had soared to tens of thousands for the rheumatoid arthritis drug Enbrel when Amgen Inc. sent its biotech SWAT team of 100 experts to Rhode Island last spring on a ...
THOUSAND OAKS, Calif., November 12, 2006 -- Amgen (NASDAQ: AMGN) today announced that Enbrel? (etanercept) is the first biologic with published data to show improvements in multiple measures of ...
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback